Abstracts tagged "Rheumatic disease"

Abstract Number: 186 • 2020 Pediatric Rheumatology Symposium
Anthropometric Assessment and Food Intake of Parents of Pediatric Patients with Chronic Rheumatic Diseases
Lucila Pereira¹, Agatha Nogueira Previdelli ², Rosana Gomes de Torres Rossi ², Wellington Douglas Rodrigues ³, Fernado Luiz Affonso Fonseca ³, Claudio Len ⁴, Roseli Oselka Saccardo Sarni ³ and Maria Teresa Terreri ⁴, ¹Federal University of Sao Paulo, Sao Paulo, Sao Paulo, Brazil, ²Sao Judas Tadeu University, Sao Paulo, Brazil, ³Federal University of Sao Paulo, Sao Paulo, Brazil, ⁴Sao Paulo, Brazil
Background/Purpose: Chronic rheumatic diseases in children and adolescents increase cardiovascular risk. Thus, knowing the eating habits, biomarkers of lipid metabolism and the lifestyle of patients…
Abstract Number: 1107 • 2019 ACR/ARP Annual Meeting
Are Rheumatologists Correctly Identifying and Controlling Traditional Cardiovascular Risk Factors?
Dionicio Galarza-Delgado ¹, Jose Azpiri-Lopez ¹, Iris Colunga-Pedraza ¹, Iván de Jesús Hernández-Galarza ¹, Ileana Cecilia Reynosa-Silva¹, Karla Paola Cuellar-Calderon ¹, Marielva Castro-Gonzalez ¹ and Carolina Marlene Martinez-Flores ¹, ¹Universidad Autonoma de Nuevo Leon, Hospital Universitario "Dr Jose Eleuterio Gonzalez", Monterrey, Nuevo Leon, Mexico
Background/Purpose: Chronic systemic inflammation generated by rheumatic diseases (RD) is related to the increased cardiovascular risk (CVR) in this population. However, the coexistence of traditional…
Abstract Number: 1212 • 2019 ACR/ARP Annual Meeting
Psychological Profile in Patients with Rheumatic Diseases in China: A Study of HADS Self-assessment with Smart System of Disease Management (SSDM)
Yongfu Wang¹, Jianhong Wu ², Yasong Li ³, Henglian Wu ⁴, Yang li ⁵, Hua Wei ⁶, Xiaoqi Chen ⁷, Bin Wu ⁸, Zhenbin li ⁹, Jinli Ru ¹⁰, Wenqiang Fan ¹¹, Shengguang Li ¹², Fang He ¹³, Yi Zhao ¹⁴, Fen Li ¹⁵, Bin Wu ¹⁶, Feng Wang ¹⁷, Miaojia Zhang ¹⁸, Lirong Kang ¹⁹, Hui Xiao ²⁰, Yuhua Jia ²¹, Bing Wu ²², Fei Xiao ²³ and Hui Song ²⁴, ¹The First Affiliated Hospital of BaoTou Medical College, Baotou, Nei Mongol, China (People's Republic), ²Dazhou Central Hospital, Dazhou, Sichuan, China (People's Republic), ³Zhejiang provincial people's hospital, Hangzhou, Zhejiang, China (People's Republic), ⁴Dongguan donghua hospital, Dongguan, Guangdong, China (People's Republic), ⁵The Second Affiliated Hospital of Harbin Medical University, Haerbin, China (People's Republic), ⁶Northern Jiangsu People's Hospital, Yangzhou, China (People's Republic), ⁷Zhongnan Hospital of Wuhan University, wuhan, China (People's Republic), ⁸The First People's Hospital of Jingzhou, jingzhou, China (People's Republic), ⁹The 980th Hospital of the PLA Joint Logistic Support Force, shijiazhuang, China (People's Republic), ¹⁰The Second Hospital of Shanxi Medical University, Shanxi, Shanxi, China (People's Republic), ¹¹Central Hospital of XinXiang, Xinxiang, Hainan, China (People's Republic), ¹²Peking University International Hospital, beijing, China (People's Republic), ¹³Suining Central Hospital, suining, China (People's Republic), ¹⁴Xuanwu Hospital, Capital Medical University, Beijing, China, beijing, China (People's Republic), ¹⁵The Second Xiangya Hospital of Central South University, changsha, China (People's Republic), ¹⁶Chongqing Hospital of Traditional Chinese Medicine, Chongqing, Chongqing, China (People's Republic), ¹⁷Central Hospital of Xiangyang, xiangyang, China (People's Republic), ¹⁸Jiangsu Province Hospital, The first affiliated hospital of Nanjing medical university, nanjing, China (People's Republic), ¹⁹The First Affiliated Hospital of BaoTou Medical College, baotou, China (People's Republic), ²⁰Shanghai Gothic Internet Technology Co., Ltd, shanghai, Shanghai, China (People's Republic), ²¹Shanghai Gothic Internet Technology Co., Ltd., Shanghai, Shanghai, China (People's Republic), ²²Shanghai Gothic Internet Technology Co., Ltd, Shanghai, China (People's Republic), ²³Shanghai Gothic Internet Technology Co., Ltd., shanghai, China (People's Republic), ²⁴Beijing Jishuitan Hospital, Beijing, Beijing, China (People's Republic)
Background/Purpose: The patients with chronic diseases such as rheumatic diseases suffer from physical pain and/or disability. In addition, psychological morbidities have also been found in…
Abstract Number: 2059 • 2019 ACR/ARP Annual Meeting
Usage of Predicting Out-of-Office Blood Pressure Calculator in Hispanic Patients with Rheumatic Diseases
Dionicio Galarza-Delgado ¹, Jose Azpiri-Lopez ¹, Iris Colunga-Pedraza ¹, Carolina Marlene Martinez-Flores¹, Marielva Castro-Gonzalez ¹, Ileana Cecilia Reynosa-Silva ¹, Karla Paola Cuellar-Calderon ¹ and Raymundo Vera-Pineda ², ¹Universidad Autonoma de Nuevo Leon, Hospital Universitario "Dr Jose Eleuterio Gonzalez", Monterrey, Nuevo Leon, Mexico, ²Universidad Autonoma de Nuevo Leon, Hospital Universitario "Dr. Jose Eleuterio Gonzalez", Monterrey, Nuevo Leon, Mexico
Background/Purpose: Subjects with rheumatic diseases have an increased risk of cardiovascular (CV) morbimortality. Hypertension (HTN) is a key modifiable risk factor for CV events. A…
Abstract Number: 2140 • 2019 ACR/ARP Annual Meeting
Preexisting Autoimmune Disease and Rheumatic Immune-Related Adverse Events Associated with Cancer Immunotherapy: A Case Series from the Canadian Research Group of Rheumatology in Immuno-Oncology (CanRIO)
Linda Laaouad¹, Janet Roberts ², Daniel Ennis ³, Carrie Ye ⁴, Karam Al Jumaily ⁵, Marie Hudson ⁶, Shahin Jamal ⁷, Janet Pope ⁸, Tatiana Nevskaya ⁹, Alexandra Saltman ¹⁰, Megan Himmel ¹¹, Aurore Fifi-Mah ¹², Annaliese Tisseverasinghe ¹³, Nancy Maltez ¹⁴, Ines Colmegna ¹⁵ and Sabrina Hoa ¹⁶, ¹University of Montreal, Montreal, Canada, ²Dalhousie University, Halifax, Canada, ³University of Toronto, Toronto, ON, Canada, ⁴University of Alberta, Edmonton, AB, Canada, ⁵University of Alberta, Edmonton, Canada, ⁶Jewish General Hospital, Lady Davis Institute for Medical Research, and Department of Medicine, McGill University, Montreal, QC, Canada, ⁷University of British Columbia, Vancouver, BC, Canada, ⁸Western University, London, ON, Canada, ⁹University of Western Ontario, London, ON, Canada, ¹⁰University of Toronto, Mount Sinai Hospital and Princess Margaret Cancer Centre, Toronto, ON, Canada, ¹¹University of Toronto, Toronto, Canada, ¹²University of Calgary, Calgary, AB, Canada, ¹³University of Manitoba, Winnipeg, MB, Canada, ¹⁴University of Ottawa, Ottawa, ON, Canada, ¹⁵McGill University Health Center, Montreal, QC, Canada, ¹⁶University of Montreal, Montreal, QC, Canada
Background/Purpose: Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy by harnessing the immune system to fight cancer, but are associated with significant immune-related adverse events…
Abstract Number: 2248 • 2019 ACR/ARP Annual Meeting
Legal Matters: Attitudes Regarding Marijuana for Medical Use Among Patients with Rheumatic and Musculoskeletal Disease
Kelly Gavigan¹, Shilpa Venkatachalam ¹, Jeffrey Curtis ², Carole Wiedmeyer ¹, Tien Sydnor-Campbell ¹, Christine Stake ¹, Terri Robinson ¹ and W. Benjamin Nowell ¹, ¹Global Healthy Living Foundation, Upper Nyack, NY, ²University of Alabama at Birmingham, Birmingham, AL
Background/Purpose: While there have been significant improvements in quality of life among people living with rheumatic and musculoskeletal disease (RMD) with the introduction of biologics…
Abstract Number: 178 • 2019 ACR/ARP Annual Meeting
Depression: A Common Comorbidity in Rheumatic Diseases. a Case-Control Study
Dionicio Galarza-Delgado ¹, Jose Azpiri-Lopez ¹, Iris Colunga-Pedraza ¹, Karla Paola Cuellar-Calderon¹, Ileana Cecilia Reynosa-Silva ¹, Marielva Castro-Gonzalez ¹ and Carolina Marlene Martinez-Flores ¹, ¹Universidad Autonoma de Nuevo Leon, Hospital Universitario "Dr Jose Eleuterio Gonzalez", Monterrey, Nuevo Leon, Mexico
Background/Purpose: Depression is a frequent comorbidity in rheumatic diseases (RD) and it is associated with chronic pain and long-term medical treatment in these patients. Furthermore,…
Abstract Number: 1078 • 2019 ACR/ARP Annual Meeting
Cardiovascular Risk Awareness in Patients with Rheumatic Diseases: A Case-Control Study
Dionicio Angel Galarza-Delgado ¹, Iris Colunga-Pedraza ², Jose Azpiri-Lopez ², Karla Paola Cuellar-Calderon², Ileana Cecilia Reynosa-Silva ², Marielva Castro-Gonzalez ² and Carolina Marlene Martinez-Flores ², ¹Universidad Autonoma de Nuevo Leon "Dr. Jose Eleuterio Gonzalez", Monterrey, Nuevo Leon, Mexico, ²Universidad Autonoma de Nuevo Leon, Hospital Universitario "Dr Jose Eleuterio Gonzalez", Monterrey, Nuevo Leon, Mexico
Background/Purpose: Cardiovascular diseases are among the most common comorbidities in patients with rheumatic diseases (RD) and leads them to an overall increase of mortality in…
Abstract Number: PP01 • 2018 ACR/ARHP Annual Meeting
Physician, Patient, Person. Success in Balancing Multiple Roles Takes Support
Brandi Stevens¹ and Katharine Moore², ¹Pediatrics, Riley Hospital for Children at Indiana University, Indianapolis, IN, ²Pediatric Rheumatology, Children's Hospital Colorado, Aurora, CO
Background/Diagnosis: It was the most important conference of the year, and I could barely walk. With a slow limping gait, there is no hiding it…
Abstract Number: 286 • 2018 ACR/ARHP Annual Meeting
The Prevalence and Treatment Patterns of Women of Childbearing Age with Rheumatic Diseases
Edward Lee¹, Robert Suruki², Brian Carpenter³, Ty Harkness³, Daniel Luk⁴ and Mohamed Yassine¹, ¹UCB Pharma, Smyrna, GA, ²UCB Pharma, Raleigh, NC, ³Charles River Associates, New York, NY, ⁴Charles River Associates, Boston, MA
Background/Purpose: Emerging data on exposure of infants to therapeutics through placental transfer and breastmilk could impact the management of women of childbearing age (WoCBA) with…
Abstract Number: 433 • 2018 ACR/ARHP Annual Meeting
Impact of Bariatric Surgery on Rheumatic Diseases: A Systematic Review and Meta-Analysis
Marie Moly¹, Bernard Combe¹, Thomas Barnetche², Claire Daien¹, Jacques Morel³, Cédric Lukas¹, Cécile Gaujoux-Viala⁴ and Charlotte Hua⁴, ¹Rheumatology, University Hospital Lapeyronie, Montpellier, Montpellier, France, ²Rheumatology, University Hospital Pellegrin, Bordeaux, Bordeaux, France, ³Department of Rheumatology, University Hospital Lapeyronie, Montpellier, Montpellier, France, ⁴Rheumatology, University Hospital Carémeau , Nimes, Nimes, France
Background/Purpose: Obesity increase the incidence of rheumatic diseases (1-3). Bariatric surgery (BS) improve obesity-related comorbidities (4). The aim of our study was to assess currently…
Abstract Number: 517 • 2018 ACR/ARHP Annual Meeting
Effects of Statin-Treatment on Coronary Plaques in Patients with Inflammatory Joint Diseases
Silvia Rollefstad¹, Mona Svanteson², Nils Einar Kløw^2,3, Jonny Hisdal⁴, Eirik Ikdahl⁵, Joseph Sexton⁶, Ylva Haig² and Anne Grete Semb¹, ¹Preventive Cardio-Rheuma clinic, Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, ²Division of Radiology and Nuclear Medicine, Oslo University Hospital, Ullevål, Oslo, Norway, ³Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway, ⁴Department of Vascular investigations, Oslo University Hospital, Aker, Oslo, Norway, ⁵Preventive Cardio-Rheuma clinic, Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, ⁶Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway
Effects of Statin-treatment on Coronary Plaques in Patients with Inflammatory Joint DiseasesBackground/Purpose: Statins have an established preventive effect on coronary artery disease in the general…
Abstract Number: 586 • 2018 ACR/ARHP Annual Meeting
Effectiveness, Tolerability, and Safety of Tofacitinib in Rheumatoid Arthritis: A Retrospective Analysis of Real-World DATA from the ST. Gallen and-Aarau RA-Cohort
Ruediger Mueller¹, Caroline Hasler², Florian Popp³, Frederik Mattow⁴, Mirsada Durmisi⁵, Andrea Rubbert-Roth⁶, Alexander Souza⁷, Nicole Graf⁸, Hendrik Schulze-Koops⁹, Paul Hasler¹⁰ and Johannes von Kempis¹¹, ¹Division of Rheumatology, Kantonsspital St Gallen, St. Gallen, Switzerland, ²on of Rheumatology, Kantonsspital Aarau, Aarau, Switzerland, ³Division of Rheumatology, Immunology and Rehabilitation, Kantonsspital St. Gallen, St. Gallen, Switzerland, ⁴Kantonsspital St. Gallen, St. Gallen, Switzerland, ⁵Division of Rheumatology, Kantonsspital Aarau, Aarau, Switzerland, ⁶Kantonsspital St Gallen, St Gallen, Switzerland, ⁷Iterata AG, Gränichen, Switzerland, ⁸Graf Biostatistics, Winterthur, Switzerland, ⁹Ludwig-Maximilians-University, Munich, Germany, Munich, Germany, ¹⁰Kantonsspital Aarau AG, Aarau, Switzerland, ¹¹Division of Rheumatology and Immunology, Kantonsspital St. Gallen, St. Gallen, Switzerland
Background/Purpose: Tofacitinib is an oral JAK inhibitor approved for the treatment of RA. Efficacy and safety of tofacitinib have been shown in several randomized clinical…
Abstract Number: 844 • 2018 ACR/ARHP Annual Meeting
Differential Roles of Tnfα-TNFR1 and Tnfα-TNFR2 in the Differentiation and Function of Induced CD4+Foxp3+ Treg Cells in Autoimmune Diseases
SONGGUO ZHENG¹, Su-juan Yang², Julie Wang¹ and Rayford June¹, ¹Medicine, Milton S. Hershey Medical School at Penn State University, HERSHEY, PA, ²Medicine, The Third Affiliated Hospital at Sun Yat-sen University, Guangzhou, China
Background/Purpose: Tumor Necrosis Factor (TNF) α exerts it pro-inflammatory or anti-inflammatory function. This study hypothesizes that TNFα has multi-function through binding the different receptor 1…
Abstract Number: 946 • 2018 ACR/ARHP Annual Meeting
Short-Term Safety of Fractional-Dose Yellow Fever Vaccination in Autoimmune Rheumatic Diseases and Kinetics of White Blood Cells
Adriana C Tonacio¹, Tatiana N Pedrosa², Julio CR Ferreira Filho², Marilia M Sampaio-Barros², Ricardo Fuller², Michelle Lopes², Eduardo Ferreira Borba², Sandra G Pasoto², Emilly Neves², Clovis A Silva³, Rosa M R Pereira⁴, Percival Sampaio-Barros⁵, Danieli Andrade², Ana CM Ribeiro², Julio CB Moraes⁶, Samuel K Shinjo⁷, Renata Miossi⁸, Hermes Higashino⁹, Silvia Costa⁹, Alberto Duarte¹⁰, Elaine P Leon², Marta Lopes⁹, Nadia E Aikawa² and Eloisa Bonfa¹¹, ¹Infectology Division, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, ²Rheumatology, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, São Paulo, Brazil, ³Pediatric Rheumatology, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, São Paulo, Brazil, ⁴Rheumatology Division, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, ⁵Rheumatology, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR., São Paulo, Brazil, ⁶Rheumatology Division, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, ⁷Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, São Paulo, Brazil, ⁸Rheumatology, Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, São Paulo, Brazil, ⁹Infectology, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, São Paulo, Brazil, ¹⁰Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, São Paulo, Brazil, ¹¹Rheumatology Division, Hospital das Clinicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil
Background/Purpose: Brazil faced a new yellow fever (YFV) outbreak that reached the state of Sao Paulo in December 2016. The fractional dose was used in…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].